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Glaucoma is defined as a progressive optic neuropathy, characterized by loss of visual function 
and often associated with high intra-ocular pressure.  Testing the patients’ visual function with 
Standard Automated Perimetry (SAP) is currently the clinical standard for detecting 
glaucomatous visual field loss. A new test algorithm using the Frequency Doubling illusion has 
been introduced on the Matrix perimeter (Humphrey Matrix; Carl Zeiss Meditech, Dublin CA) 
that measures the central 10˚ using a 2˚x 2˚ square flickering stimulus.  This stimulus has the 
theoretical advantage of being both a large target, with good repeatability, and being perceptually 
selective, by preferentially stimulating the magnocellular projecting ganglion cells.   
 
The purpose of this thesis was to determine the within-technique, between-visits repeatability and 
the within-visit, between-technique comparison of several techniques available to measure the 
central 10˚ visual field in patients with late stage glaucoma. In particular, to examine test-retest 
variability and compare sensitivity threshold values, visual field indices, and total and pattern 
deviation probability maps among the following techniques:  Full Threshold SAP 10-2 size III 
(SAP III), Full Threshold SAP size V (SAP V), SITA SAP 10-2 size III (SS III), and Matrix 10-2 
2˚ stimulus (M2). 
 
Forty nine patients with advanced glaucomatous visual field defects attended 3 visits.  During 
each visit, 1 eye was examined with each of the 4 techniques mentioned above.  Data from the 
first visit was discarded to eliminate bias that may occur from the learning effect. Coefficient of 
Repeatability values of SAP III, SAP V, SS III, and M2 were calculated to be 10.33, 9.00, 9.90, 
and 12.04%dB respectively, relative to the average difference in threshold estimates between 
iii 
visits.  M2 had the most uniform test-retest characteristics across the full range of sensitivities; 
however the 90% confidence interval was the widest of all techniques in the normal to near 
normal range (24 to 38dB).  Threshold estimates of SAP III and SS III were shown to be similar 
and slightly more variable than SAP V.  M2 showed less severe defects than SAP III in the 
pattern deviation probability plots.  Compared to SAP III and SS, M2 estimated sensitivity as less 
severe.  Estimates of 20 dB and above on M2 were estimated at approximately 30 dB with SAP V. 
In the moderate to abnormal sensitivity range, Matrix estimated points to be shallower than that 
estimated by SAP V. 
 
This thesis showed that M2 has lower sensitivity than SAP but shows fewer abnormal points than 
SS or SAP III  and test-retest variability of the SAP techniques decreased with increasing 
sensitivity whereas; variability was constant throughout the dynamic range for M2 and smaller in 
the moderate to severe range.  However M2 was worst in the normal to near-normal sensitivity 
range.  This suggests that M2, compared to all SAP techniques, will be disadvantaged for the 
detection of early visual field loss but better positioned to repeatably detect and follow moderate 
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1.1 Glaucoma and Automated Perimetry 
 
Glaucoma is a general term that encompasses a range of ocular conditions that cause a specific 
neuropathy of the optic nerve1.  It is the second leading cause of blindness in the world2 and can 
occur in all age groups but is most common in the elderly1.  Glaucoma is characterized as 
progressive optic nerve damage associated with visual function loss1, 3, 4. The most common 
clinical method of measuring the function of the visual system is the assessment of the eye’s 
ability to detect the brightness of small points of light projected in both the central and peripheral 
areas of vision, also known as perimetry or visual field testing5.  The detection of visual field 
abnormality in glaucoma is an indicator of optic nerve damage6.  Testing the patients’ visual field 
using standard automated perimetry (SAP) is currently considered to be the gold standard for 
detecting glaucomatous visual field loss6, 7, 8; SAP uses stationary or static targets of varying 
brightness, so called static perimetry, to determine functional glaucomatous changes9.   
 
The development of early glaucoma is a very gradual process10.  Local depressions of sensitivity 
often appear and disappear before becoming stable defects in the patients’ visual field10.  The 
defects, commonly referred to as scotomas, then begin to enlarge and follow the arcuate pattern 
of the retinal nerve fibres.  In the advanced stages of glaucoma, large arcuate scotomas from the 
superior and inferior field break through into the peripheral field and connect leaving only the 
central or temporal visual field intact11. 
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Although SAP is used as the gold standard for perimetry testing, the stimulus is broadband in 
nature and not selective for any particular ganglion cell subtype.  Newer techniques have been 
developed which are aimed at selectively testing subsets of ganglion cells that may be more prone 
to damage caused by glaucoma (selective loss hypothesis)12 or better reflect generalized ganglion 
cell loss (selective testing hypothesis)13.  For example, Short-Wavelength Automated Perimetry 
(SWAP) projects a blue target onto a high luminance yellow background14 to selectively examine 
the short-wavelength sensitivity (SWS) pathway14 which are believed to be damaged early in 
glaucoma15, 16, 17, 18, 19.  Frequency Doubling (FD) Technology selectively tests magnocellular cells, 
which are stimulated by the FD illusion20, 21.  It is believed that magnocellular projecting ganglion 
cells may be selectively damaged in glaucoma12 as compared to parvocellular cells22.  Previous 
studies have shown that the contrast sensitivity perceived with the FD illusion is reduced in 
patients with glaucoma23, 24, 25 hence, selectively testing for magnocellular cells may be key in 
detecting and monitoring early glaucoma.  An alternate to this theory is the Reduced Redundancy 
Hypothesis as proposed by Johnson13.  This hypothesis states that early functional loss can be 
detected by testing subpopulations of ganglion cells that have reduced redundancy, or a sparse 
distribution throughout the retina.  In such a situation defect may be detectable earlier when 
compared to that detected using a more general stimulus. It has been shown that FDT is effective 
at detecting patients with moderate to severe glaucoma26, 27, 28.  For early glaucoma, sensitivity 
and specificity of the FDT has been reported as 85% and 90%, respectively; due to its short 
duration, resistance to blur and pupil size, it may be a useful screening tool for glaucoma29.  The 
high temporal frequency and low spatial frequency required to perceive the frequency doubling 
illusion suggests that it is preferentially mediated by the magnocellular pathway30.  This pathway 
is particularly responsive to high temporal frequency, low spatial frequency, and achromatic 




1.2 Automated Perimetry 
 
Automated perimetry is a diagnostic examination technique used for assessing visual function9, 32, 
33 including patients who have glaucoma, or are a glaucoma suspect34.  Today, a person’s visual 
field is tested with automated perimeters and standard thresholding algorithms (SAP)35 which 
have improved our ability to quantify visual function36.  Perimetry testing may be the only means 
of detecting progression in late stage glaucoma as the optic disc will no longer be a reliable or 
accurate indicator for progression37.   
 
The purpose of a visual field examination is to detect defects, determine the specific pattern of 
visual field loss for diagnostic purposes, and monitor patients for evidence of visual field 
progression38, 39, 40.  In patients with glaucoma, the observed patterns of visual field abnormalities 
correspond to the anatomy of the nerve fiber layer of the retina and its projections to the optic 
nerve41.   
 
1.2.1 Humphrey Field Analyzer 
 
1.2.1.1 Instrument Specifications 
 
The Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Dublin, CA, USA) is most commonly 
used in clinical settings for assessing visual function; it uses contrast sensitivity testing to analyze 
a person’s visual field sensitivity.  Standard Automated Perimetry, also known as white-on-white 
perimetry, is the standard technique available on the HFA.  Standard automated perimetry uses a 
white stimulus of a specific size (usually 0.43º diameter, Goldmann size III) on a white 
background of specific luminance (10cdm-² or 31.5 asb).  This background illumination was 
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specifically chosen for the Goldmann perimeter, the previous clinical gold standard perimeter, 
because it is the minimum amount of light needed for photopic vision to function, i.e. for 
stimulation of the cones as well as the rods10.  The subject is asked to respond to the flash of light 
by pressing a button.  According to the intensity value(s) the patient responds to, the instrument 
will calculate the sensitivity at each stimulus location throughout the visual field.  The result is 
expressed as a decibel (dB) value representing the minimum brightness the patient can see at each 
point10.  The target(s) used by standard automated perimetry (SAP) can stimulate a wide spectrum 
of retinal ganglion cells within a tested retinal location8, 42. 
 
The 30-2 program on the HFA tests 76 points within the central 30 degrees, separated by 6˚ and 
offset from the horizontal and vertical meridians by 3˚43.  The central 10-2 program tests 68 
points in a grid within the central 10 degrees, each separated by 2˚ and offset from the horizontal 
and vertical meridians by 1˚43, 11.  STATPAC is a statistical software package installed in the 
Humphrey perimeter which provides rapid analysis including a comparison of the patients’ 
threshold values with that of normal age-based population, at the time of the exam10, 44.  
 
1.2.1.2 Goldmann Stimulus Size 
 
The Goldmann stimulus size I-V targets are used with techniques available on the Humphrey 
Field Analyzer (HFA).  These targets are smaller in size when compared to the blind spot (which 
is roughly 5 by 7 degrees)10.  The Goldmann size III (0.43˚ diameter) stimulus is the most 
commonly used with SAP because it provides a valid assessment of neural loss45.  The Goldmann 
size V (1.73˚) has been used with SAP in cases of severe glaucomatous visual field loss. The 






Figure 1.1:  Relative comparison of Goldmann stimulus sizes I-V with the blind spot. 
 
1.2.1.3 Test Procedures 
 
Although the development of automated perimetry has greatly increased the precision and 
consistency of visual field results as compared to manual perimetry46, new techniques are 
continuously being developed to help decrease test variability and increase sensitivity and 
specificity.  A variety of test procedures are available which estimate threshold values47.  The use 
of a standardized test procedure for automated perimetry testing will have a great impact on the 











1.2.1.3.1 Bracketing Strategy 
 
The commercially available Humphrey uses a bracketing strategy to estimate threshold levels41.  
In general, the threshold values for all Humphrey strategies are calculated from this repetitive up-
and-down staircase technique10; the patient’s response to the stimulus will determine whether the 
subsequent stimulus intensity will increase or decrease48.  Therefore, if a patient responds to a 
stimulus, the subsequent stimulus at that location will be presented at a lower contrast level; this 
will continue until the patient does not respond to the presented stimulus.  When this point is 
reached, the computer will increase the intensity of the target by a smaller step, if the patient 
responds then the following stimulus is presented at a lower intensity by an even smaller step.  
This reversal is repeated several times until consistent responses are obtained.  The threshold is 
calculated with respect to the lowest intensity the patient responds to.  As severity of the field loss 
increases, fewer stimulus presentations are needed to estimate the threshold at the given stimulus 
location49. The Humphrey perimeter uses a 4-2dB staircase. 
 
 
1.2.1.3.2 Swedish Interactive Test Algorithm  
 
The Swedish Interactive Test Algorithm (SITA) is a family of test algorithms designed to 
significantly reduce the test time for threshold estimation available on the HFA, without any 
reduction in data quality7, 29, 50.  Swedish Interactive Threshold Algorithms use maximum 
likelihood methods to estimate threshold values51.  Each test location has two likelihood functions 
each derived from normal and glaucomatous visual fields52, 53, 54.  At the beginning of each test, 
threshold values for four predetermined test locations are calculated; these values are then used to 
calculate the initial intensity for the stimuli to be presented at adjacent test locations51.  The 
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patient’s responses to the stimuli at each location along with previously computed distributions51 
are used to calculate probability distributions; thus, the probability distribution at each location 
changes with each successive response51.  The peak of the distribution represents the threshold 
value and the width determines its accuracy51 hence, the narrower the distribution the more 
accurate is the estimate.   
 
The SITA threshold testing algorithm has allowed perimetry testing to be more accurate and 
reliable with shorter test duration7.  They are significantly faster than the standard full threshold 
algorithm, however, an increase in severity of the visual field decreases time saved7.   
 
1.2.2 Frequency Doubling Perimetry 
 
1.2.2.1 Instrument Specifications  
 
The Frequency Doubling Technology (FDT) is a perimetry technique which simultaneously 
exploits the utility of contrast sensitivity, spatial frequency and temporal modulation55.  The 
commercially available FDT employs a sinusoidal grating of 0.25 cycles per degree undergoing 
counterphase flicker at 25 Hertz56. 
  
The phenomenon of FD is experienced when a low spatial frequency sinusoidal grating is 
combined with a high temporal frequency counter phase flicker57, 58, 59, 60.  Thus, the subject 
perceives a stimulus with twice the number of bands spaced more closely3.    For the frequency 
doubling effect to occur, the grating must have a spatial frequency <4 cycles per degree and 
counterphase at a temporal rate >15 Hertz56.  The subject is asked to respond by pressing a button 
when he/she is able to see the target.  The threshold of the visual field is determined by the 
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amount of contrast that the target had at the time a response was recorded.  Figure 1.2 shows a 




Figure 1.2:  Schematic diagram of the Frequency Doubling Illusion.   
 
Studies have shown that the frequency doubling perimetry is effective at detecting moderate to 
severe cases of glaucoma12, 61 and shows promise as a screening tool for early glaucoma12, 23, 61, 62 
with very good sensitivity and specificity23, 53.Because of the low spatial frequency of the target53, 
the frequency doubling stimulus is resistant to blur up to 6 diopters; thus visual correction is not 
necessary with lower degrees of refractive error12, 53.  Patients typically respond to the perception 
of any stimulus, irrespective of whether a frequency-doubled illusion is visible64. 
  
Frequency doubling perimetry is attractive in the clinical setting because the test is resilient to 
refractive errors and blur, it has a large dynamic range, and threshold test strategies are short in 
<4 cycles/degree 
>15 Hz counterphase flicker 
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duration65.  Also, test-retest variability with increase in defect severity does not increase as much 
with FDT as compared with SAP65.  
 
A study by Cello et al26 showed very high sensitivity and specificity values of the FDT in early, 
moderate, and advanced stages of glaucoma.  The FDT 30-2 technique has shorter test duration as 
compared to conventional perimetry66, however, the MD and PSD of the FDT results show a 
strong linear correlation with that of the Humphrey 30-2 technique55.  These findings indicate that 
the performance level of the FDT is comparable with that of the full-threshold test strategies used 
in conventional automated perimetry. It is also possible that this technique can be used to detect 
and characterize the severity of glaucomatous visual field loss26. 
 
The Matrix is a new perimeter developed by Welch-Allyn to measure sensitivity of the visual 
field.  It was developed as a means of improving efficiency and accuracy of the original 
Frequency Doubling Technology (FDT).  In comparison to FDT, the Matrix (also known as FDT 
II (Welch Allyn, Skaneateles Falls, NY; Carl Zeiss, Meditech, Dublin CA) uses a smaller 
stimulus size allowing for more test locations to be tested thereby giving more detail on the 
spatial distribution of the visual field loss67.   
 
1.2.2.2 Testing Procedures 
 
1.2.2.2.1 Modified Binary Search 
 
The Modified Binary Search (MOBS) test procedure is used by the commercially available FDT 
for the Full Threshold test68.  A range of possible thresholds sets the upper and lower thresholds 
for the patient at each test location.  An average contrast value of the upper and lower threshold 
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limit is calculated as the target contrast for the initial presented stimulus.  The patient’s response 
to the target determines the interval from which the contrast for the proceeding stimulus at that 
location will be calculated.  This process is continued until a certain number or response reversals 
are met and the difference between the upper and lower threshold is equal to or less than a 
predetermined interval69; this information is used to calculate the threshold values.  An advantage 
of MOBS is that it can recover quickly from response error and it can make large jumps to remain 
close to the correct location of threshold69. 
 
1.2.2.2.2 Zippy Estimation of Sequential Testing 
 
Threshold values for the Matrix are calculated using an adaptation of the Zippy Estimation of 
Sequential Thresholds (ZEST) procedure67, 70.  At each test location, 4 stimuli are presented, each 
with a predetermined intensity and corresponding pdf curve71, 72; the pdf curve is modified for the 
next presentation with respect to the patients’ responses (“seen” or “not seen”)67.  The 15 possible 
combinations of “seen/not seen” responses to the 4 stimuli presented determine the threshold 
estimates ranging from 0 to 38 dB67 i.e. a frequency-of-seeing curve is obtained71.  ZEST has 
been shown to be just as accurate and reproducible as the MOBS procedure with a 40% decrease 
in testing time in both normal and glaucomatous patients72.  The time saved with this procedure 
helps decrease the effect of patient fatigue. 
 
1.3 Testing Boundaries 
 
Perimetry tests best suited for the early stages of glaucoma may not be well suited for later stages 
of the disease and its progression42.  Testing the central 30˚ of the visual field in the early stages 
of glaucoma can give a good sense of the disease and its progression.  However, as the disease 
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progresses into the later stages, when only a small portion of the central visual field is intact, 
switching to a technique which measures the visual function of the central 10˚ can provide a more 
detailed assessment of visual field progression.  A retrospective study by Zalta43 has shown that 
SAP 10-2 size V is able to measure visual function that is undetected by SAP 30-2 size III.  
 
1.4 Sensitivity Values 
 
Threshold and visual sensitivity, as measured in decibels (dB), are inverse functions.  The dB 
scale is a logarithmic scale that is inversely related to luminance and each dB is equal to 0.1 log 
units with the SAP and approximately 0.05 log units with the Matrix67. The more sensitive a 
person is to a specific stimulus at a specific location, the lower his/her threshold is at that point of 
the visual field.  Usually, neighboring points in the visual field have similar thresholds48.  The 
most important aspect of the visual field lies in the accuracy of determining the sensitivity73 at 
each determined location.  The probability of seeing a stimulus presented at threshold is 50%72.   
 
1.5 Reliability Parameters  
 
In order to use perimetric data to accurately evaluate visual field loss, it is crucial to know the 
reliability of the results which depend to a great extent on the patient’s ability to consistently 
perform the perimetric task29, 74, 75.  The reliability also depends strongly on the reproducibility of 
its results75.  Fixation losses (FL), false positive (FP), and false negative (FN) calculations, as 
reported on the perimetry test printout, are an indication of the reliability and validity of the test.  
Fixation losses provide a relative idea of how well the patient kept his or her eye fixed on the 
fixation target during the test.  Throughout the test, at random intervals, a stimulus is projected in 
the area of the blindspot (the instrument locates the area of the blindspot at the beginning of the 
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test)76 at an intensity the patient is able to perceive; the number of times the patient reports seeing 
such stimuli is recorded alongside the other reliability indices26, 48.   
 
The false positive rate (FP) is presented as a ratio of the total number of times the subject 
responds without a stimulus being presented, divided by the total number of times the instrument 
pauses without presenting a stimulus77.  A patient is termed “trigger happy” when he/she has a 
high false positive rate, i.e. frequently clicks the button when no stimulus is presented.  False 
negative errors usually result when the subject fails to respond to a distinctly visible stimulus10 in 
a location outside of the determined blind spot.  The false negative rate (FN) is presented as a 
ratio of the total number of times the subject fails to respond when a stimulus of 9 dB higher than 
the previously determined threshold sensitivity at that location is presented, divided by the total 
number of such presentations77, i.e. failing to respond to stimulus with 100% contrast26.  In the 
presence of severe visual field loss, FN is not used to define reliability due to the low number of 
catch trials43.    
 
The SITA algorithm calculates FP and FN differently than described above.  False positives are 
calculated by recording positive responses when none are expected, i.e. within the minimum 
reaction time interval after a stimulus is shown78.  False negatives are calculated based on the 
patient’s pattern of responses after the test is completed79.  Different data from FP and FN are 
combined and the maximum likelihood method is used to calculate FP and FN responses as a 
percentage80.  This method of estimating the frequency of FP and FN responses helps reduce 
testing time. 
 
Vertex Monitoring and Gaze Tracking are features available on HFA II.  The former ensures that 
the patient’s eye is centered behind the lens at a proper distance, eliminating the trial lens as a 
possible source for unreliable results.  The latter is used to determine the patients’ fixation during 
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the test.  This is done by using real-time image analysis.  A gaze track graph is displayed on the 
printout.    
 
1.6 Statistical Plots:  Total Deviation, Pattern Deviation and Probability Maps 
 
Total deviation (TD) values and its related probability plot are calculated on techniques which 
have a normal database available.  The TD plot is composed of positive and negative integers 
which correspond to the difference in sensitivity between the subject and age-matched normal 
data at each point of the visual field9, 10.  Total Deviation plots are useful because they accentuate 
areas of the visual field which fall outside the normal range10.  Its corresponding probability map 
indicates how different the given results are from that of the normal41, 81. 
 
A pattern deviation (PD) plot and its related probability plot are also calculated with respect to a 
normal database.  This particular plot allows for the field test results to be compensated with 
respect to the subject’s height of the hill of vision10, i.e. it eliminates defects caused by a 
generalized shift in sensitivity9.  Thus, it signifies the difference in shape of the measured hill-of-
vision as compared with that of the normal population82.  This allows for differentiation of 
localized visual field loss from that resulting from age-related conditions such as small pupils and 
cataract formation10.   
 
Probability maps are used to evaluate the normality of the data83.  It compares the threshold 
values of the patient with that of the age-matched normal database, if one is available for the 




1.7 Global Indices   
 
Statistical analysis of visual fields has become a useful tool in interpreting on the results from 
automated perimetry84.  Visual field indices are a statistical review of the retinal light sensitivities 
which are designed to recognize and evaluate the extent of visual field damage36.  They are used 
to facilitate interpretation of the results from a single perimetric examination36.  It assists the 
interpreter with defining visual field loss by summarizing the data obtained from the test85, 86. 
Visual field indices, Mean Deviation (MD) and Pattern Standard Deviation (PSD) are calculated 
based on previously acquired normal data63.     
 
Mean deviation is determined by averaging the deviation from normal for all points tested74.  It 
quantifies overall change of visual field loss with respect to normal data of age-matched 
controls34, 39, 63, 87.  Pattern standard deviation measures the extent to which the tested field 
deviates from the shape of the “normal hill of vision”74. It is an index for showing localized 
change in the visual field34, 63, 87.   
 
1.8 Glaucoma Hemifield Test 
 
The Glaucoma Hemifield Test (GHT) is an algorithm that evaluates glaucomatous visual field 
loss from visual field sensitivity data of a single visual field test88; it is only applicable to 
glaucomatous defects9, thus it should be disregarded if a visual defect other than glaucoma is 
suspected.   
 
Each hemifield of the visual field is divided into 5 sectors as illustrated in the Figure 1.3, which 
correspond to the normal retinal nerve fibre layer (RNFL) anatomy.  Each test location is 
 15
assigned an ordinal score with respect to the pattern deviation probability map probability score; 
the deeper the defect, the higher the score88.  Every sector of the superior hemifield is compared 
to the mirror-image sector of the inferior hemifield, and a difference of the sum of probability 
scores is calculated.  These differences are compared with the limits of normality to identify the 
“category” of the patient’s visual field status.  The GHT classifies visual fields into five 
categories: i) within normal limits, ii) borderline, iii) outside normal limits, iv) generalized 
reduction insensitivity, and v) abnormally high sensitivity88, 89.  The last category is for tests with 
high false positive results, also known as “trigger happy patients”. 
 
Figure 1.3:  Partition of the visual field for Glaucoma Hemifield Test analysis.  Each hemisphere is  










Although the GHT may seem like a reasonable method of classifying glaucomatous visual field 
loss, it should be noted that, like other visual field indices, it will fail to reflect the true nature of 
the disease in far-advanced glaucoma cases90.  This is explained by the actuality that in far-
advanced glaucoma, both the superior and inferior hemifields of the visual field will be severely 
damaged and hence, very little or no difference will be noted between them.   
 
1.9 Glaucoma Stage Classification 
 
Many studies use the MD value from the Humphrey Field Analyzer to classify glaucomatous 
visual field loss.  The most commonly used classification is that of Hodapp, Anderson and 
Parish91.  They categorize glaucomatous visual field loss into the following:  i) early, ii) moderate, 
and iii) late.  The classifications are made using the Humphrey 30-2 technique, which measures 
76 test locations in a 6˚ x 6˚ grid covering the central 30˚ of the visual field.   
 
To classify a defect as “early”, the MD must be worse than -6 dB; the PD plot should have fewer 
than 18 points depressed below the 5% probability level and fewer than 10 points below the 1% 
level and no point in the central 5˚ of the visual field with sensitivity less than 15 dB.  A defect is 
classified as “moderate” when the MD is worse than -12 dB; the PD plot has fewer than 37 points 
depressed below the 5% level and fewer than 20 points depressed below the 1% level.  No point 
in the central 5˚ of the visual field with sensitivity of 0 dB and only one hemifield within 5˚ of 
fixation may have a sensitivity less than 15 dB. 
 
A severe defect consists of the following findings:  MD worse than -12 dB, more than 37 points 
depressed below the 5% level on the PD plot, check if TD or PD or more than 20 points 
depressed below the 1% level on the PD plot.  Any point in the central 5˚ visual field with 
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sensitivity of 0 dB and points within the central 5˚ with sensitivity less than 15 dB in both 
hemifields.   
 
The Advanced Glaucoma Intervention Study (AGIS) classification of glaucoma uses the total 
deviation plot from the HFA 24-2 technique to assign a score from 0 to 2092; 0 indicating no 
visual field loss and 20 indicating end-stage disease.  A total of 52 test locations are available on 
the total deviation plot:  6 locations in the nasal region and 23 in each hemifield.  Each sector is 
scored based on the number and depth of defect and then the scores are summed to give the defect 
score32. 
 
The Glaucoma Staging System (GSS)92 categorizes glaucoma into 6 stages, stages 0 (normal) to 
V (end-stage), based on Humphrey visual field results.  A series of criteria must be met before 
classification into the appropriate stage.  Mean Deviation is the primary measure for 
categorization; Pattern Standard Deviation, hemifield test, dB plot and pattern deviation plots are 
secondary factors.  If the patient meets the criteria set for MD, but fails to meet the additional 
criteria for that stage, then he or she is placed in the preceding or succeeding stage depending on 
which additional criteria is met. 
 
1.10 Frequency Doubling Perimetry in Glaucoma  
 
The frequency doubling stimulus was found to be a promising stimulus for glaucoma testing23.  A 
study by Spry et al40 comparing SAP and FDT in normal individuals and patients with glaucoma 
showed that FDT exhibited significantly lower variability especially in areas of depressed 
sensitivity; the Matrix has been shown to have constant variability over its dynamic range in 
patients with early to moderate glaucoma67.  The FDT has been shown to be effective at detecting 
moderate to severe glaucoma and is well suited as a screening tool for the disease61.  Many 
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studies have shown the FDT to have good sensitivity and specificity for detecting glaucoma24, 62, 
164, 165.  A study by Cello et al26 has shown FDT to have high sensitivity and specificity for all 
stages of glaucoma.  These findings suggest that use of FD illusion may be suitable for 
monitoring patients with this disease.  
 
1.11 Large Stimulus Testing in Glaucoma 
 
Using larger stimuli in the later stages of glaucoma may yield additional information regarding 
the patients’ visual field95, 96.  The use of Goldmann size V, instead of the standard size III, in 
SAP has been shown to decrease variability in areas of moderately damaged to normal sensitivity 
in patients with glaucoma97, 98. Goldmann size V has been shown to measure visual function in 
areas where size III has measured as absolute defect95.  Testing only the central 10˚ visual field 
and using Goldmann size V stimulus has been shown to be better at monitoring changes in the 




Perimetry is essential for the management of glaucoma10.  The developments of new perimetry 
techniques are aimed at providing shorter test duration, and optimum sensitivity and specificity.  
Different perimetry techniques are designed to test different aspects of retinal physiology.  
Standard Automated Perimetry is currently the gold standard for measuring retinal sensitivity of 
patients with glaucoma.  Because of its inability to selectively test subsets of ganglion cells, it 




Previous studies26, 27, 28 have shown that the FDT is very useful in measuring visual field depth in 
patients with moderate to severe stages of glaucoma.  We want to see if this holds true for the 
Matrix in patients with late stage glaucoma using the 10-2 technique.  We also want to determine 
if use of larger target size and different algorithms available on SAP provides a better means of 
evaluating visual field sensitivity in patients with late stage glaucoma.   
 
1.13 Research Questions 
 
Does choice of algorithm affect the repeatability and defect characteristics of perimetry testing in 
patients with late stage glaucoma?   
Is the small FD stimulus, as available on the Matrix, more repeatable than SAP in late stage 
glaucoma? 
Is the FD stimulus capable of measuring visual field depth and area when compared to the 
standard automated perimetry? 
 
1.14 Objectives  
 
The global aim of this thesis was to determine the capability of different perimetry techniques, 
available on the Humphrey Field Analyzer and Matrix instruments, to estimate retinal sensitivity 
in various locations within the central 10˚ visual field of patients with late stage glaucoma.  The 
following techniques were used:  i) Full Threshold SAP 10-2 size III (SAP III), ii) Full Threshold 
SAP 10-2 size V (SAP V), iii) SITA SAP 10-2 size III (SS III), and iv) Matrix 10-2 size 2˚ (M2). 
 
The primary objective of this study was to determine which perimetry technique, the SAP III, 
SAP V, the SS III, or the M2, was most repeatable and better able to detect functional loss in the 





1. The Matrix shows more extensive and deeper field defect than Standard Automated 
Perimetry. 
2. SAP V will show the least amount of visual field defect but will be the most repeatable 
technique. 
4. No significant difference is expected between the results of SAP III and SS III. 





















2 Methods   
 
2.1 Sample Size Calculation 
 
The sample size for this study was calculated with the following formula:  
   
 
where η is the sample size,  is equal to the chosen confidence limit on a standard normal 
distribution,  is the population standard deviation as obtained from previous studies, and E is 
the margin of error (the maximum difference between techniques).  
For this study, we chose a 95% confidence interval therefore, α = 0.05, and  = 1.96 and E = 1.  
Similar studies performed previously have reported = 3.30.  Substituting these values into the 
equation, we get: 
 
    η  = [(1.96)(3.30)/1]2 
        = 42 
 
Although our sample calculation indicates that an η of 42 will provide statistically significant 








2.2 Study Sample Demographics 
 
The study sample demographics are listed in Table 2.1. 
 
Table 2.1:  Study Sample Demographics 
______________________________________________________________________________________ 
              Ratio   Average            Maximum             Minimum 
______________________________________________________________________________________ 
Males: Females    30:19     ----      ----      ----  
Eyes (Right: Left)   31:18     ----       ----             ---- 
Age (years)     ----           68.37 + 9.79      84      46 
HFA Trial Lens Used (Diopters)  ----     ----     -9.25    +5.25 
Pupil Size (mm)    ----             3.55 + 0.54     5.00      3.00 
Visual Acuity    ----     ----       6/6      6/21 
Intraocular Pressure (mmHg)  ----           11.91 + 3.28      20       4 
Time Elapsed Between Visits (days)              ----           17.43 + 24.67      85       1  
Time Elapsed Between Visits (weeks) ----             2.49 + 3.52    12.14     0.14 
______________________________________________________________________________________  
 
Table 2.1 describes the patient demographics. The study sample consisted of 30 males and 19 
females.  31 right eyes and 18 left eyes were included in the study.  The mean age, standard 
deviation and range for this group was 68.4 + 9.79 years and 46 to 84 years, respectively.  The 
refractive error ranged from -9.25 to +5.25.  The pupil sizes varied from 2 to 5 mm in diameter 
without dilation; tropicamide ½% was used to dilate pupils which were less than 3 mm in 
diameter to ensure that pupil size was not a contributing factor to visual field defect.  Visual 
acuity ranged from 6/21 to 6/6.  Intraocular pressure (Applanation Tonometry) ranged from 5 to 
20 mmHg. 
 
2.3 Inclusion/Exclusion Criteria 
 
The subjects were recruited from the Glaucoma Department at the Toronto Western Hospital 
based on SITA-Standard 24-2 test results performed within six months of recruitment.  Patients 
with advanced field loss were considered as possible candidates for participation in the study.  
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Advanced field loss was defined as a visual field with only the central or temporal portion of the 
central 10˚ visual field intact. Only patients who gave reliable results were recruited, i.e. false 
positive (FP), false negative (FN), and fixation losses (FL) less than 15%, 15%, and 30%, 
respectively74.   
 
Patients were excluded if they had one or more of the following:  Visual acuity worse than 6/24; a 
defect in the visual field of the eye being tested that was explained by the patient’s ocular status 
or history other than late stage glaucoma; history of disease or use of medication that may affect 
visual field reliability, or ability to undergo either perimetry test.  If both eyes qualified for the 
study, then the eye to be included was chosen at random.   
 
2.4 Definition of Disease Stage  
 
Hodapp E et al91 categorize glaucomatous visual field loss into the following:  i) early, ii) 
moderate, and iii) late.  The Humphrey 30-2 technique was used to make the classification.  A 
total of 76 test locations are tested with this technique. 
A severe defect consists of the following findings:  MD worse than -12 dB, more than 37 points 
depressed below the 5% level or more than 20 points depressed below the 1% level using the PD 
plot.  Any point in the central 5˚ visual field with sensitivity of 0 dB and points within the central 
5˚ with sensitivity less than 15 dB in both hemifields.   
For the purposes of this study, we defined late stage glaucoma as the condition with only the 
central or temporal portion of the central 10˚ visual field remaining on the grayscale plot of HFA 






The study was approved by the University of Waterloo, Office of Research Ethics, and the 
University Health Network.  Written consent was obtained from each of the subjects prior to 




Patients were given an ophthalmic examination consisting of the following:  Goldmann 
applanation tonometry, slit lamp examination of the anterior segment of the eye, and dilated 
ophthalmic examination including LOCS II grading system for the evaluation of the crystalline 
lens.   
 
This cross-sectional study compared perimetry results from the central 10˚ visual field  of patients 
with severe glaucoma, using the following perimetry techniques: i) Full Threshold SAP 10-2 size 
III, ii) Full Threshold SAP 10-2 size V, iii) SITA SAP 10-2 size III, and iv) Matrix 10-2 2˚.  We 
wanted to see whether or not the results would vary with the use of different stimulus variables 
and/or algorithms. 
 
Each subject attended for three visits.  During each visit, one eye from each patient was examined 
with each of the four perimetry techniques.  The order of the testing for each patient was random 
but remained constant for each patient; this was done to eliminate any bias that may be caused 
from the “carryover effect”.  Subjects were given ample time to rest between the tests (at least 5 
minutes) to eliminate the effect of fatigue on proceeding tests. 
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In this study, the global indices, sensitivity values, and probability plots among the various visual 
field techniques were compared.    
 
2.7 Analysis  
 
The results from Visit 1 were discarded to eliminate any bias that may result from the learning 
effect.  The patient’s age and severity of visual field were considered as separate between-subject 
factors and the order of perimetry testing were considered as within-subject factors; this allowed 
for direct comparison of the visual field data of patients with different patterns and severity of 
glaucomatous visual field loss.  All threshold estimates with a value less than 0 dB were given a 
value of 0 dB.  At locations with two threshold estimates the average value was used.   
 
The Humphrey Field Analyzer 10-2 program tests 68 points whereas the Matrix 10-2 program 
tests only 44 points.  In order to directly compare the results from both instruments, the test grids 
from each technique were superimposed and the threshold estimates from the HFA were 
recalculated to fit the test grid of the Matrix.  Figure 2.1 displays the overlapping test grids from 
all techniques used, with respect to stimulus size.  The squares are those of the Matrix, the small 
closed circles are those of SAP size III, and the larger open circles are those from SAP size V.  
All threshold estimates from SAP which overlapped onto a single Matrix test point were averaged; 
this was now the threshold value used for comparison purposes.  The center co-ordinates of all 
overlapping points from SAP and Matrix were less than 2˚ apart.  No threshold estimates were 






Figure 2.1:  Overlapping Coordinates.  Stimulus locations of the 10-2 algorithms for both right and  
left eyes:  SAP size III (small closed circles), SAP size V (large open circles), and Matrix 
size 2˚ (open squares).  For comparison purposes, the 68 test points from the SAP 
techniques used were recalculated to fit the 44 test grid of the Matrix.  All points from 
SAP which overlapped onto a Matrix test point were averaged; this was now the 
threshold value used for comparison purposes.  The centers of overlapping points from 
SAP and Matrix were less than 2˚ apart. 
 
The data from Visits 2 and 3 were compared using ANOVA (Analysis of Variance), test-retest 
plots, and Bland-Altman plots for within-technique, between-visit data analysis.  The same 
statistical analyses were used to determine the within-visit, between-technique comparison of the 
data obtained from Visit 3. ANOVA was used to compare the visual field indices and sum of 
quadrants for the techniques studied.   
 
Plots of test-retest variability analyze the variability of follow-up data with respect to its 
baseline77.  Test-retest can only be a valid measurement of variability if no actual change has 
taken place, i.e. no progression of the glaucomatous visual field.  This analysis shows the range of 
values with the greatest variability upon repeated measures.  
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Bland-Altman99 plots analyse the average of two paired variables versus their differences.  These 
plots have been used for method-comparison and validity studies.  Calculations of the 5th and 95th 
percent confidence limits define the interval at which 90% of the follow-up data fall.  The 
narrower an interval is calculated to be, the less variable is the follow-up data, and hence the 
technique is regarded more repeatable.       
 
The frequency of differences in threshold points between visits was calculated within each 
technique globally and for threshold values of 32dB, 27dB, 23dB, 18dB, 13dB, and 7dB at Visit 2.  
The frequency of data points was plotted as a function of decibel difference.  The smaller the 
interval at which the fraction of data points reaches 100%, the less variable is that technique for 
the specified threshold estimate. 
 
Principal curve analysis (PCA) was used to determine the relationships among the techniques.  
All data from test locations were excluded if at least one threshold estimate was 0 dB; this was 














3 Repeatability of Standard Automated Perimetry and Frequency Doubling 
Perimetry in the Central 10˚ Visual Field of Late Stage Glaucoma 
 
Balian C1,2, Kourkoutas D1, Buys YM1, Trope GE1, and Flanagan JG1,2.  1Department of 
Ophthalmology and Vision Science, University of Toronto, Toronto, ON, Canada; 2School of 




Purpose:  To determine test-retest characteristics of the central 10o visual field as measured by 
Standard Automated Perimetry (SAP, target size III and V) and Frequency Doubling Perimetry 
(Matrix) in patients with late stage glaucoma.   
Methods:  49 patients with advanced glaucomatous visual field defects attended three visits.  
During each visit, one eye was examined with Full Threshold SAP 10-2 size III (SAP III), Full 
Threshold SAP 10-2 size V (SAP V), SITA Std 10-2 size III (SS III), and Matrix 10-2 2˚ stimulus 
(M2).  The Coefficient of Repeatability (CoR) was calculated to determine overall repeatability 
within each technique.  Threshold values from Visits 2 and 3 were averaged and plotted against 
their differences and the mean of differences and limits of agreement were calculated.  Test-retest 
characteristics were also plotted and compared. Visual field defects were compared using the total 
and pattern deviation probability maps.   
Results:  CoR values of SAP III, SAP V, SS III, and M2 were calculated to be 10.33, 9.00, 9.90, 
and 12.04%dB respectively, relative to the average difference in threshold estimates between 
visits.  M2 had the most uniform test-retest characteristics across the full range of sensitivities; 
however the 90% confidence interval was the widest of all techniques in the normal to near 
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normal range (24 to 38dB).  M2 showed the greatest defects in both total and pattern deviation 
probability plots.     
Conclusion:  Test-retest variability increased with decreasing sensitivity in all SAP techniques.  
M2 showed constant variability throughout its dynamic range but it was also greatest in the 
normal to near normal range.  This suggests that the M2 would have the most difficulty in 
following visual field progression in early disease but may be better than SAP techniques in 




Glaucoma is defined as a progressive optic neuropathy, characterized by loss of visual function 
and often associated with high intra-ocular pressure4.  It has been suggested that in late stage 
disease tests of visual function may be the optimum means of detecting progression101.  Testing 
the patients’ visual function with Standard Automated Perimetry (SAP) is currently the clinical 
standard for detecting glaucomatous visual field loss7, 8. It has also been suggested that moderate 
to late stage disease should be followed by testing the central 10˚ of the visual field rather than 
the standard 30˚ field3.  Furthermore, it has been proposed that the larger Goldmann size V 
stimulus offers advantages for the evaluation of central field defect and its progression95. 
However there has been concern that the large target size results in apparently shallower defects. 
A new test algorithm using the Frequency Doubling illusion has been introduced on the Matrix 
perimeter (Humphrey Matrix; Carl Zeiss Meditech, Dublin CA) that measures the central 10˚ 
using a 2˚x 2˚ square flickering stimulus102.  This stimulus has the theoretical advantage of being 
both a large target, with good repeatability, and being perceptually selective, by preferentially 
stimulating the magnocellular projecting ganglion cells.          
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Standard Automated Perimetry (SAP), also known as white-on-white perimetry, projects a white 
Goldmann size III (0.43˚) stimulus of specific intensity onto a white background with a 
luminance of 10 cd/m2 (31.5 apostilbs)10.  Standard AP provides a broadband stimulus that is 
non-selective with respect to retinal ganglion cell type42.  The commercially available Humphrey 
uses a bracketing strategy to estimate threshold levels41.  In general, the threshold values for all 
Humphrey strategies are calculated from this repetitive up-and-down staircase technique10; the 
patient’s response to the stimulus will determine whether the subsequent stimulus intensity will 
increase or decrease48.  This will continue until the patient does not respond to the presented 
stimulus.  When this point is reached, the computer will increase the intensity of the target by a 
smaller step, if the patient responds then the following stimulus is presented at a lower intensity 
by an even smaller step.  This reversal is repeated several times until consistent responses are 
obtained.  The threshold is calculated with respect to the lowest intensity the patient responds to.  
The Humphrey perimeter uses a 4-2-2dB staircase, and records the last seen response as the 
differential light sensitivity. 
 
The Swedish Interactive Test Algorithm (SITA) is a family of test algorithms designed to 
significantly reduce the test time for threshold estimation, available on the HFA, without any 
reduction in data quality7, 29, 50.  Swedish Interactive Threshold Algorithms use maximum 
likelihood methods to estimate threshold values51.  Each test location has two likelihood functions 
each derived from normal and glaucomatous visual fields51, 53, 54.  At the beginning of each test, 
threshold values for four predetermined test locations are calculated; these values are then used to 
calculate the initial intensity for the stimuli to be presented at adjacent test locations51.  The 
patient’s responses to the stimuli at each location along with previously computed distributions51 
are used to calculate probability distributions; thus, the probability distribution at each location 
changes with each successive response51.   
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The Matrix uses a Zippy Estimation of Sequential Testing (ZEST) algorithm for threshold 
estimation67. This procedure starts with a flat probability density function (pdf)72.  At each 
location, a sequence of 4 stimuli are presented, the pdf curve is modified by the patients’ 
responses (“seen” or “not seen”) to each stimulus and the threshold is recorded as the mean of the 
final pdf curve67.  There are 15 possible outcomes over a range from 0 to 38 dB67.   
 
The purpose of this study was to determine the within-technique, between-visits repeatability of 
several visual field techniques available to measure the central 10˚ visual field in patients with 
late stage glaucoma. In particular, to examine test-retest variability of sensitivity threshold values, 
visual field indices, and total and pattern deviation probability maps among the following 
techniques:  Full Threshold SAP 10-2 size III (SAP III), Full Threshold SAP size V (SAP V), 




49 subjects were recruited from the Glaucoma Service at Toronto Western Hospital, University 
Health Network, Toronto.  The study sample consisted of 30 males and 19 females; 31 right eyes 
and 18 left eyes.  The mean age was 68.4 + 9.79 years ranging from 46 to 84 years.  Subject 
recruitment was based on the results of a SITA-Std 24-2 test, performed within the six months 
prior to recruitment using the criteria of Hodapp et al91.  The Hodapp criteria for late stage 
glaucoma states that the following is found when using the Humphrey 30-2 program:  MD worse 
-12 dB, more than 37 points depressed below the 5% level on the PD plot, check if TD or PD or 
more than 20 points depressed below the 1% level on the PD plot.  Any point in the central 5˚ 
visual field with sensitivity of 0 dB and points within the central 5˚ with sensitivity less than 15 
dB in both hemifields.  Patients with only a temporal or central field remaining in the central 10˚ 
grayscale plot of the SITA-SAP 24-2 size III test were considered as possible candidates for 
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participation in the study.  Aside from the defect, the patient must have had a reliable test, i.e. 
false positive (FP), false negative (FN), and fixation losses (FL) must have been less than 20%, 
20%, and 30%, respectively.   
 
Patients were excluded if they had one or more of the following: Visual acuity worse than 6/24 
(equivalent to 20/80), a visual field defect in the eye being tested that is explained by the patient’s 
ocular status or history other than late stage glaucoma, any history of disease or use of medication 
that may affect visual field reliability, and inability to undergo any of the perimetry tests.  The 
eye that best fit this inclusion criterion was included in the study, if both eyes were qualified, then 
the eye to be included in the study was chosen at random.   
 
Refractive error ranged from -9.25 to +5.25 diopters, which was calculated from the patients 
current prescription.  The pupil sizes varied from 2 to 5 mm in diameter without dilation; ½% 
tropicamide was used to dilate pupils which were less than 3 mm in diameter to ensure that pupil 
size was not a contributing factor to the visual field defect.  Visual acuity ranged from 6/21 
(20/70) to 6/6 (20/20).  Intraocular pressure was measured by Goldmann applanation tonometry 
and ranged from 5 to 20 mmHg.   
 
Each subject was scheduled for three visits during which the following four perimetry techniques 
were performed:  i) SAP III, ii) SAP V, iii) SS III, and iv) M2.  The order of the tests varied 
between subjects but remained constant for each subject. The patients were also given ample time 
between tests to rest in order to minimize the effect of fatigue. All patients were experienced with 
the SAP and SS III techniques but had no experience with SAP V, or M2.  Consequently, data 
obtained from Visit 1 was discarded to eliminate any bias that may result from the learning effect.   
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In order to determine repeatability, comparisons were made using global indices, threshold 
estimates and probability plots.  The study was approved by the institutional research ethics 




All threshold estimates with a value less than 0 dB were given a value of 0 dB.  At locations with 
two threshold estimates the average value was used.  The patient’s age and the severity of the 
visual field defect were considered as separate between-subject factors.  Table 3.1 displays the 
mean and standard deviation for the visual field indices Mean Deviation (MD) and Pattern 
Standard Deviation (PSD), and test duration.  Due to lack of a normal database, SAP V does not 
provide global indices.  No significant differences were found between visits (p>0.05).   
 
Table 3.1:  Visual Field Indices and Examination Duration 
___________________________________________________________________________________ 
 
Index                           Visit          Full Threshold                   SITA                     Matrix 
                   Size III               Size V           Standard   
____________________________________________________________________________________ 
 
Mean Deviation (dB)               2         -14.12 + 7.22  ----         -14.24 + 7.29         -15.35 + 6.82 
            3         -14.23 + 7.31            ----         -14.38 + 7.59    -15.30 + 6.97 
Pattern Standard Deviation (dB)      2          10.45 + 2.85   ----    10.79 + 3.31       7.72 + 2.54 
           3          10.58 + 2.77   ----    10.59 + 2.89       7.43 + 2.67 
Examination Duration (minutes) 2          13:37 + 2:34   14:53 + 1:46      7:50 + 0:55       4:23 + 0:12 
    3          13:27 + 2:26   14:53 + 1:41      7:50 + 1.18       4:21 + 0:10 
____________________________________________________________________________________ 
Values are the Group Means + 1 SD. 
 
 
The Student’s t-test was used to compare quadrant sums between visits for each technique (Table 
3.2).  Calculations of Coefficient of Variability (CoV) and Coefficient of Repeatability (CoR) 
were made using the results from Visit 2, Visit 3 and Visit 2 & Visit 3 (Table 3.3).  Test-retest 
variability within techniques was plotted as a function of visual field sensitivity (Figure 3.1).  
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Threshold estimates from Visits 2 and 3 were compared.  This analysis illustrates the 5th and 95th 
confidence limits in which 90% of follow-up threshold estimates are likely to fall, provided no 
real change has occurred.  The frequency of differences in threshold estimates between visits was 
calculated within each technique globally (Figure 3.2) and for threshold values of 32dB, 27dB, 
23dB, 18dB, 13dB, and 7dB, (Figure 3.3) corresponding to available endpoints available when 
using the Matrix technique, at Visit 2.  The frequency of data points was plotted as a function of 





Table 3.2:  Student’s t-test:  Visit 2 vs Visit 3; Sum of Quadrants  and Mean Sensitivity (MS) 
             Q1                Q2           Q3                Q4           MS 
_______________________________________________________________________________  
 
FT SAP 10-2, size III      0.68 (N)          0.90 (N)          0.84 (N)        0.79 (N)       0.94(N) 
FT SAP 10-2, size V               0.95 (N)         0.85 (N)           0.93 (N)        0.99 (N)       0.74(N) 
SITA SAP 10-2, size III      0.74 (N)         0.85 (N)           0.98 (N)        0.81 (N)       0.93(N) 
Matrix 10-2, 2˚ stimulus         0.54 (N)         0.79 (N)           0.78 (N)        0.85 (N)       1.00(N) 
___________(c. size V)___________________________________________________________ 
p-values 
R- Reject H0 
N- Not reject H0 
 
Table 3.3:  CoV and CoR Values___________________________________________________ 
 
 Technique      CoV Visit 2     CoV Visit 3      CoR (excluding 0dB) 
_______________________________________________________________________________ 
 
Full Threshold SAP 10-2, size III         74.67         75.92           10.33 
Full Threshold SAP 10-2, size V         51.84         50.07             9.00 
SITA SAP 10-2, size III          70.28                    71.87                       9.90 
Matrix 10-2, 2 degree stimulus         79.71                    78.28           12.04  
_______________________________________________________________________________ 
All values are in decibels (dB). 
CoV – Coefficient of Variability 








   
   
Figure 3.1: Test-retest plots showing the 95th, 50th, and 5th percentiles for the distribution of  
sensitivity across all test points for each technique.  The threshold sensitivity from Visit 3 
for each given location is plotted with respect to the threshold sensitivity value of Visit 2 










Figure 3.3:  Frequency of differences for threshold estimates of 32 dB, 27 dB, 23 dB, 18 dB, 13 dB,  
       and 7 dB at Visit 2.   
 
Total Deviation (TD) and Pattern Deviation (PD) Probability plots from Visits 2 and 3 were 
compared for each technique (Figure 3.4). Because the SAP V algorithm does not have a normal 
database, this technique was excluded from the analysis.  Each test location was assigned an 
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ordinal value corresponding to its probability value; p >5%, p <5%, p <2%, p <1%, and p <0.5% 
were given the values 0, 2, 5, 10, and 10, respectively.  The scores were then summed across all 
test locations to give a defect score for each subject. This technique is similar to the approach 
used to calculate the Glaucoma Hemifield scores88.  This defect score was used to compare the 
total and pattern deviation probability maps between the two visits. 
 
Table 3.4:  Statistics from Frequency of Differences Graphs.  Maximum dB difference of 90% of  
     data points. 
______________________________________________________________________ 
Technique Global    32 dB    27 dB       23 dB      18 dB          13 dB       7 dB__ 
 SAP III            9             3             5         8               15            12            12 
 SAP V            6             3             5              8               11            15            11 
 SS III       9      2       4              8               15            13            11 














Figure 3.4:  Defect scores of total and pattern deviation scores were tallied for each technique.   
      Ordinal scores of 0, 2, 5, 10 and 10 were assigned to the probability calculations at each  




Table 3.5:  Regression Analysis for Total and Pattern Deviation Probability  
     Plots Ordinal Score Graphs  
__________________________________________________________ 
 
Technique  Total Deviation  Pattern Deviation 
__________________________________________________________ 
 
SAP III            0.8418      0.6912 
SS III       0.8382      0.8688 
M2        0.9359      0.8228 
__________________________________________________________ 




Table 3.1 lists the global indices and test duration for each technique studied.  No significant 
within test difference was found between Visits 2 and 3 for any of the parameters. Table 3.2 
shows the Student’s t-test for the sum of quadrants for each technique, and shows no within test 
difference between visits.  CoV and the CoR for all techniques studied are displayed in Table 3.3.  
SAP V was calculated to have the least variability and best repeatability followed by SS III, SAP 
III, and then M2 with the highest overall variability and lowest repeatability.   
 
Figure 3.1 displays the test-retest characteristics of each technique. The mean, 95% and 5% 
confidence limits were plotted for the range values recorded in Visit 3 for a specific stimulus 
level in Visit 2. If a certain threshold value appeared less than five times during Visit 2 it was 
excluded from this analysis.  These graphs are in agreement with the CoV and CoR calculations 
shown in Table 3.1.  The SAP techniques showed lowest variability in areas of normal to near 
normal sensitivity; however, variability increased as sensitivity decreased.  SAP V was the least 
variable.  The test-retest plot of M2 showed consistent variability throughout the instruments 
dynamic range.   
 
 40
Bland & Altman plots of repeatability comparing threshold estimates between visits for each 
technique are displayed in Figure 3.5.  The average of the two corresponding points was plotted 
against their difference.  The Limits of Agreement (90% confidence intervals) were least for SAP 




Figure 3.5:  The sensitivity values with respect to stimulus location of Visit 2 vs Visit 3 for each  
technique with the Mean and +2 standard deviations.  The differences between Visits 2       
and 3 are plotted with respect to the average of the two sensitivity values. All pairs of 





Table 3.6:  Statistics from Bland & Altman Plots________________________________________ 
 
Technique Mean of Differences +2 SD  -2 SD Limits of Agreement (90% CI) 
 
SAP III                      0.03  10.36              -10.30    20.66 
SAP V            0.40    9.40  -8.60    18.00 
SS III           -0.12    9.78              -10.02                 19.80 
M2            0.00  12.00              -12.00    24.00 
_________________________________________________________________________________ 
All values are in decibels (dB). 
 
Figure 3.2 illustrates the cumulative frequency for the difference in threshold estimates between 
visits. A similar analysis was performed for six threshold levels:  32dB, 27dB, 23dB, 18dB, 13dB, 
and 7dB (Figure 3.3).  The Matrix had the highest percentage of datapoints with a difference of 0 
dB between visits.  The fraction of datapoints with 0dB difference between visits decreased with 
decreasing sensitivity for all techniques; this value was greatest for the M2 technique.   
 
Figures 3.2 and 3.3 plot the frequency of data points as a function of dB difference between visits.  
Globally, M2 showed the greatest fraction of threshold locations with 0 dB difference between 
visits, but by 2 dB it was the worst performer. 90% of the data for all techniques showed, at most 
10 dB difference between visits.  The relative performance of each technique changes at different 
stages of the measurement dynamic range.  At 32 and 27 dB, 90% of the data from SAP showed 
less than 3 and 5 dB difference, respectively; whereas 90% of data from M2 showed a maximum 
difference of 8 dB.  In the moderate to moderately-severe threshold estimates, the dB difference 
between visits for 90% of the data started to increase.  At 13 dB, M2 showed a greater number of 
points with less difference than SAP.  The dB difference for M2 is fairly consistent throughout 
the threshold estimates. 
 
Figure 3.4 illustrates the correlation between the total and pattern deviation probability map 
defect scores for each technique.  All techniques showed good repeatability upon retest. 
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3.6 Discussion  
 
Test-retest variability in perimetry is dependent upon stimulus characteristics such as target size 
and color97, the stage of visual field defect being studied77 and the algorithm used to estimate the 
sensitivity52.  Previous reports have shown disturbingly high levels of test-retest variability, 
particularly in areas of moderate to severe defect, implying that the following of disease 
progression is problematic77, 103. It is therefore important to determine the variability within a 
technique to decide whether or not it might be suitable to measure visual field loss and/or 
progression.  Previous studies have claimed that the Matrix has uniform test-retest variability 
across its dynamic range in patients with early to moderate glaucomatous visual field loss in 
comparison to standard automated perimetry67.  The main objective of this study was to determine 
repeatability and the test-retest characteristics of M2 and SAP in techniques used to measure the 
central 10˚ visual field of patients with late stage glaucoma.   
 
Test duration showed no significant difference between visits; the techniques with a normal 
database also showed no significant difference in any of the global indices.  The CoV and CoR 
were calculated to give a global analysis of the variability and repeatability for each technique 
across the full range of data. The Matrix gave the highest scores in each measurement thereby 
suggesting that it was the most variable and least repeatable technique.  Of the HFA techniques 
SAP V gave the most repeatable results due to its larger size and greater spatial summation97, but 
surprisingly SAP III was more repeatable than SS III.  However, these measures summate data 
from the entire dynamic range.  The point-by-point analysis in Figure 3.1 describes in detail the 
repeatability at specific sensitivity estimates.  Overall, variability of SAP techniques follow the 
same trend:  it decreases as sensitivity increases.  However, variability of this trend is seen among 
its techniques.  SAP III has the widest variability and SAP V has the narrowest.  Size V showed 
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least variability upon retest as it has the potential of stimulating a larger receptive field within the 
retina.  This agrees with previous studies that Goldmann size V is more suitable for monitoring 
visual field progression in late stage glaucoma than either technique using size III stimuli104. 
 
The Bland and Altman graphs illustrate the large test-retest values in the mid-range of defect for 
all instruments.  The Matrix gave the largest Limits of Agreement, but the smallest Mean of 
Differences.  This tells us that there is no difference between the means of Visits 2 and 3; 
however, variability of M2 was greater than any SAP technique.  Interestingly the Matrix also 
showed a peculiar clustering of points due to the truncated options for final threshold estimation. 
This is due to the nature of the 4 step Zest procedure, which results in 15 specific choices for the 
final threshold estimation (0, 2, 3, 6, 7, 11, 12, 13, 18, 20, 23, 27, 32, 34, 38)72.The distribution of 
points on the Bland & Altman graphs restates that areas of near normal to normal sensitivity are 
more repeatable with SAP. All SAP techniques show upper limits of their range of repeatability, 
particularly in the 10 to 20 dB range, to be no better than chance for measuring the same 
sensitivity at repeated visits. 
  
The test-retest graphs for the various SAP techniques in Figure 3.1 show good repeatability in the 
normal range but are greatest at locations of moderate to severe abnormality.  In the normal range, 
M2 has the greatest test-retest characteristics but has the advantage of being constant throughout 
its dynamic range.  This would imply that it would perform relatively poorly with respect to 
repeatability in the normal to near normal range but better than the SAP techniques in the 
moderate to severe defect range.  This might be considered ironic given that frequency doubling 
is promoted as a technique optimized for early detection. 
 
Frequencies of dB differences between visits are illustrated in Figures 3.2 and 3.3.  Globally, M2 
had the highest fraction of 0 dB difference, but the lowest proportion within ±2dB .  This can be 
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attributed to the fact that M2 has a smaller number of final threshold estimates compared to SAP 
(i.e. 15 vs 39); hence the convergence of raw threshold values to the specific threshold estimates 
is greater than that of SAP.  The graphs which show differences at specific threshold estimates 
confirm that variability increases as sensitivity decreases with SAP techniques.  Size V showed 
least variability upon retest as it has the potential of stimulating a larger receptive field within the 
retina.   
 
Comparison of defect scores from total and pattern deviation probability maps showed good 
overall repeatability within each technique.  In comparison to each other, M2 calculated test 
points within defects to be shallower than the SAP techniques.  However, this analysis has limited 
significance as the defect score of SAP techniques was calculated from 68 points and the Matrix’ 
from 44.  
 
In conclusion, this study showed that test-retest variability of the SAP techniques decreases with 
increasing sensitivity in patients with late stage glaucoma.  SAP III has the widest variability and 
SAP V has the narrowest.  This agrees with previous studies which show that Goldmann size V is 
more suitable for monitoring visual field progression in late stage glaucoma than either technique 
using size III stimulus104.  However, variability was confirmed to be constant throughout the 
dynamic range for M2 but is worst in the normal to near-normal sensitivity range.  This suggests 
that M2 will be disadvantaged for the detection of early visual field loss but better positioned to 
repeatably detect and follow moderate to severe loss, compared to SAP when considering the 
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Purpose:  To compare results of Standard Automated Perimetry (SAP) and Frequency Doubling 
Perimetry  (Humphrey Matrix; Carl-Zeiss Meditech, Dublin, CA) in patients with late stage 
glaucoma.   
Methods:  49 patients with advanced glaucomatous visual field defects were enrolled in the study.  
Each patient attended three visits.  During each visit, one eye was examined with Full Threshold 
SAP 10-2, size III (SAP III); Full Threshold SAP 10-2, size V (SAP V); SITA Std 10-2, size III 
(SS III); and Matrix 10-2, 2˚ stimulus (M2).  Results from Visits 2 and 3 were compared. The M2 
test grid pattern was used to compare results, with the SAP techniques being summated for spatial 
equivalence.  Mean Deviation (MD) and Pattern Standard Deviation (PSD) were compared using 
the limits of agreement and regression analysis.  Principal curve analysis compared threshold 
estimates between techniques.  Total and pattern deviation probability maps were also compared.       
Results:  A correlation was noted among MD but not PSD values.  Threshold estimates of SAP 
III and SS III were shown to be similar and slightly more variable than SAP V.  M2 had the 
widest 90% confidence interval in the normal to near normal sensitivities and showed a constant 
variability throughout its dynamic range.  SAP showed greater defects than M2 in pattern 
deviation probability plots. 
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Conclusion:  M2 gives a lower sensitivity than the SAP techniques, but identifies fewer abnormal 
test locations than SS or SAP III.  This is likely due to the relatively poor test-retest 
characteristics in the near normal range. However; it may better suited to following progression in 





Glaucoma is characterized as a progressive optic neuropathy associated with visual function loss4. 
Measurement of visual function by static perimetry is an integral part of the diagnosis and 
management of the disease9.  In patients with late stage glaucoma, treatment is aimed at 
prolonging the function of the central 10˚ of vision. Testing the patients’ visual field using 
standard automated perimetry (SAP) is currently considered to be the gold standard for detecting 
glaucomatous visual field loss7, 8.  Standard automated perimetry, also known as white-on-white 
perimetry, projects a white stimulus of specific intensity onto a white background with a known 
luminance, often the Goldmann standard 31.5 apostilbs (10cdm-2)10.  More recently there have 
been other types of stimuli available to test and monitor visual function in glaucoma. One such 
stimulus uses the frequency doubling (FD) illusion, in which a grating of low spatial frequency is 
flickered at a high temporal frequency57, giving the percept of a doubling of spatial frequency3.  It 
has been shown that the FD illusion stimulus used for perimetry is principally a flicker stimulus105 
and is processed cortically64. 
 
In the advanced stages of glaucoma, large arcuate scotomas from the superior and inferior field 
connect leaving only the central and/or temporal visual field intact11.  Testing only the central 10˚ 
visual field and using a Goldmann size V stimulus have both been suggested as better methods 
for monitoring progression in these patients43, 104.   
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The primary objective of this study was to determine the differences between perimetry 
techniques when measuring visual field sensitivity in patients with late stage glaucoma (within-





The sample consisted of 49 patients with glaucoma recruited from the Glaucoma Department, 
Toronto Western Hospital, University Health Network, Toronto.  There were 30 males and 19 
females; 31 right eyes and 18 left eyes.  The mean age was 68.4 + 9.79 years ranging from 46 to 
84 years.  Subject recruitment was based on prior visual fields measured within 6 months (SITA-
SAP 24-2).  Patients were considered as possible candidates for participation in the study if they 
had only a temporal or central island of vision remaining within the central 10˚.  Patients were 
also required to have a reliable test, defined as a false positive (FP) and false negative (FN) score 
of less than 20% and fixation losses (FL) of less than 30%.   
 
Patients were excluded if they had one or more of the following:  visual acuity worse than 6/24 
(20/80), a defect in the visual field of the eye being tested other than glaucoma, that is explained 
by ocular status or history, any history of disease or use of medication that may affect visual field 
reliability, and inability to undergo any of the perimetry tests.  The eye that fit these inclusion and 
exclusion criteria was included in the study, if both eyes qualified, then the eye to be included in 
the study was chosen at random. 
  
Each subject was scheduled for three visits during which the following 4 perimetry techniques 
were performed:  i) SAP III, ii) SAP V, iii) SS III, and iv) M2.  The order of the tests varied 
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between subjects but remained constant for each subject to avoid any carryover effect that may 
occur amongst the perimetry techniques.  The patients were also given a minimum of 5 minutes 
to rest between tests in order to minimize the effect of fatigue. 
 
All patients had prior experience with SS III and/or SAP III, but no experience with either SAP V 
or M2.  Data obtained from Visit 1 was discarded to eliminate bias that may result from the effect 




All threshold estimates with a value less than 0 dB were given a value of 0 dB.  At locations with 
two threshold estimates the average value was used.  The age and severity of the visual field of 
each subject were considered as separate between-subject factors.   
 
The Humphrey Field Analyzer tests 68 points with its 10-2 program whereas the Matrix tests only 
44 points.  To directly compare results from both instruments, the test grid from each were 
superimposed and the threshold estimates from the HFA were recalculated to fit the test grid of 
the Matrix.  Figure 4.1 displays the overlapping test grids from all techniques used, with respect 
to stimulus size.  All threshold estimates from SAP which overlapped onto a single Matrix test 
point were averaged; this value was used as the threshold estimate for that test location.  The 
center co-ordinates of all overlapping points from SAP and Matrix were less than 2˚ apart.  No 





Figure 4.1:  Overlapping Coordinates.  Stimulus locations of the 10-2 algorithms for both right and  
left eyes:  SAP III (small closed circles), SAP V (large open circles), and M2 (open 
squares).  For     comparison purposes, the 68 test points from the SAP techniques used 
were recalculated to fit the 44 test grid of M2.  All points from SAP which overlapped 
onto a Matrix test point were averaged; this was the threshold value used for comparison 
among the techniques.  The centers of overlapping points from SAP and M2 are less than 
2˚ apart. 
 
Analysis of Variance (ANOVA) was used to compare the mean deviation (MD) and pattern 
standard deviation (PSD) from Visit 3 of SAP III, SS III, and M2 stimulus techniques.  Quadrant 
sums of sensitivity were also performed and included SAP V.  Regression analysis was used to 
compare, MD and PSD, and test duration among the different techniques. 
 
Threshold estimates among the techniques were compared using principal curve analysis100 which 
calculates the line of best fit while minimizing residuals of both variables67. The average 
threshold estimates from Visits 2 and 3 were used for each test location.  Data sets from test 
locations with a value of 0 dB were excluded to eliminate an artifactual decrease in test variability 




Point-by-point analysis was used to show the within-visit, between-algorithm variability between 
the techniques.  This analysis outlines the 5th and 95th confidence limits within which 90% of the 
threshold estimates from the two techniques being compared are likely to fall.  The intervals for 
each pair of techniques were calculated by comparing threshold estimates from Visit 3.  
Coefficient of Repeatability (CoR) and Coefficient of Variability (CoV) were also calculated, 
with respect to threshold estimates, for each of the techniques being studied. 
 
Visual field defects as recorded on Total Deviation (TD) and Pattern Deviation (PD) probability 
plots were compared between the techniques.  Because SAP V algorithm does not provide 
probability maps, this technique was excluded from this analysis.  Each test location was assigned 
an ordinal value corresponding to its probability value; p >5%, p <5%, p <2%, p <1%, and p 
<0.5% were given the values 0, 2, 5, 10, and 10, respectively. This technique is similar to the 
approach used to weight the Glaucoma Hemifield scores88.  The 44 data points from the Matrix 
was recalculated to fit the 68 point grid from SAP; this was to endure that all data points were 
assigned one of the predetermined ordinal values.  The ordinal values were summed for each 
visual field resulting in a defect score.  This defect score was used to compare the TD and PD 




Refractive error ranged from -9.25 to +5.25 diopters.  The pupil sizes varied from 2 to 5 mm in 
diameter without dilation; tropicamide ½% was used to dilate pupils which were less than 3 mm 
in diameter to ensure that pupil size was not a contributing factor to the visual field defect.  
Visual acuity ranged from 6/21 to 6/6.  Intraocular pressure ranged from 5 to 20 mmHg, by 
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Goldmann applanation tonometry.  False positive and false negative values ranged from 0 to 20% 
while fixation losses ranged from 0 to 30%. 
 
There was no significant difference between techniques for MD but there was a significant 
difference for PSD (Table 4.1).  Table 4.2 displays the p-values from ANOVA for the quadrant 
sums of all the techniques.  The results from Visits 2 and 3 were similar and show a strong 
correlation.  The threshold values for all the techniques show similar results with respect to each 
quadrant, irrespective of stimulus type and/or size.  There was a strong correlation for MD among 
the three techniques (Table 4.3).  However, this relationship was not seen with PSD (Table 4.4).  
As might be expected, the strongest correlation was between SAP III and SS III (r2= 0.8439, 
p<0.00), which were designed to give similar results.  This relationship has been reported 
previously1, 109.  SS III and M2 showed the greatest difference in their PSD calculations (r2= 
0.4925, p<0.00).   
Table 4.1:  ANOVA:  Full Threshold SAP10-2 size III, 
_________SITA SAP 10-2 size III, and Matrix 10-2 
  MD  PSD   
_____________________________________ 
 
Visit 2          0.6396 (N)         <0.0001 (R)  
 
Visit 3         0.7348 (N)         <0.0001 (R)          
______________________________________ 
P-values 
R- Reject H0 
N- Not reject H0 
 
Table 4.2:  ANOVA:  Full Threshold SAP10-2 size III, Full Threshold  
_________SAP 10-2 size V, SITA SAP 10-2 size III, and Matrix 10-2_ 
  Q1          Q2                  Q3           Q4 
___________________________________________________________ 
 
Visit 2          <0.0001 (R)     <0.0001 (R)    <0.0001 (R)    <0.0001 (R) 
 
Visit 3         <0.0001 (R)     <0.0001 (R)    <0.0001 (R)    <0.0001 (R) 
___________________________________________________________ 
P-values 
R- Reject H0 




Table 4.3:  Mean Deviation Regression Analysis_______________________________ 
         SITA SAP 10-2 size III         Matrix 10-2 size 2˚ 
________________________________________________________________________ 
 
FT SAP 10-2 size III        r2 = 0.9434 (p<0.00)                      r2 = 0.7016 (p<0.00) 
 




Table 4.4:  Pattern Standard Deviation Regression Analysis_____________________ 
         SITA SAP 10-2 size III          Matrix 10-2 size 2˚ 
________________________________________________________________________ 
 
FT SAP 10-2 size III         r2= 0.8439 (p<0.00)                   r2= 0.4925 (p<0.00) 
 





Principal curve analysis was used to determine the relationship of threshold estimates between 
techniques.  In Figure 4.2 (top left), a fairly linear relationship was seen between the average 
threshold estimates of SAP III and SS III, where the correlation was strongest in the normal 






   
 
Figure 4.2:  Principal curve analysis for comparison of thresholds among techniques.  For each pair  
      of thresholds, if at least one value was 0 dB then the pair was excluded from this analysis. 
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Differences in threshold estimates as a result of using different stimulus size with SAP, is seen in 
the graphs comparing SAP V with SAP III (Figure 4.2, top right) and SS (Figure 4.2, middle left).  
Both curves have slopes of approximately 1.5-2.0 at threshold estimates of >25dB as recorded by 
SAP V.  At sensitivity values <25dB, the slope of the curve rapidly approaches 0.  Hence, 
correlation between techniques decrease considerably as sensitivity is reduced.  
 
Comparison of SAP V and M2 is seen in Figure 4.2, bottom right.  With respect to this curve, M2 
shows damage numerically three times more severe than SAP V in areas of normal sensitivity.  
However, at sensitivity estimates <30dB, the slope of the curve rapidly approaches 0.  Hence, 
there is no agreement between the two techniques at sensitivity values <30dB. 
 
In comparison to SAP III and SS, the distribution of M2 is divided into three sections (Figures 4.2 
middle left and bottom right).  In sensitivity values >25dB as estimated with SAP III and SS, the 
slope of the curves are between 2.0 and 3.0.  Between 10 and 25dB the correlation is very weak, 
as the slope rapidly approaches 0.  Sensitivity values below 10dB, correlation increases to 1.5 and 
2.0 times for SAP III and SS, respectively.    
 
Figure 4.3 displays the mean, 95% and 5% confidence limits of threshold sensitivity values for 
each pair of techniques being compared.  This will show the variability in sensitivity obtained 
from one technique to another.  If a certain threshold value appeared less than five times in the 
entire threshold estimates, it was excluded from this analysis.  With techniques available on SAP, 
variability is reduced in areas of near-normal to normal sensitivity.  In comparison to M2, 
variability is constant throughout the sensitivity range, hence greatest in the near-normal to 
normal range of sensitivity values. 
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Figure 4.3:  The 95th, Mean, and 5th percentiles for the distribution of sensitivity across all test points  
among the techniques.  The sensitivity between each technique from Visit 3 for each 
given    location is plotted with respect to the threshold value of another technique (i.e. 
within-visit, between-algorithm analysis).  
 
Figure 4.4 displays the Mean and + 2 standard deviations for comparing sensitivity values 
obtained within the techniques during Visit 3.  The average of the two points is plotted against the 
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dB difference between them.  The results from the Bland & Altman graphs are in compliance 
with the test-retest plots and CoR & CoV calculations (Table 4.5).  Coefficient of Repeatability 
values of SAP III, SAP V, SS III, and M2 were calculated to be 10.33, 9.00, 9.90, and 12.04%dB 
respectively, relative to the average difference in threshold estimates between visits.  Coefficient 
of Variability of SAP III, SAP V, SS III and M2 at Visit 3 were calculated to be 75.92, 50.07, 

















Figure 4.4:  The sensitivity values with respect to stimulus location of Visit 3 within techniques with  
the Mean and +2 standard deviations.  The difference between threshold estimates of the 




Table 4.5:  CoV and CoV Values 
______________________________________________________________________________________ 
 Technique      CoV Visit 2     CoV Visit 3      CoR              CoR (without 0dB) 
______________________________________________________________________________________ 
 
Full Threshold SAP 10-2, size III         74.67         75.92      11.05     10.33 
 
Full Threshold SAP 10-2, size V         51.84         50.07       9.50                    9.00 
 
SITA SAP 10-2, size III          70.28                    71.87                10.95                    9.90 
 
Matrix 10-2, 2 degree stimulus         79.71                    78.28     11.77                  12.04  
______________________________________________________________________________________ 
All values are in decibels (dB). 
CoV – Coefficient of Variability 
CoR – Coefficient of Repeatability  
 
 
Total Deviation (TD) and Pattern Deviation (PD) probability plots were compared using ordinal 
scoring in Figure 4.5.  Probability plots of SAP III and SS III are shown to give nearly identical 
results.  In comparison to M2, both SAP III and SS III show more severe defects in the PD 












Figure 4.5:  Defect scores of total and pattern deviation probability maps for SAP III, SS III, and M2.   
Ordinal scores of 0, 2, 5, 10 and 10 were assigned to the probability calculations at each 
test location.  
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Table 4.6 displays the regression analysis for test duration among the techniques studied.  No 
significant difference was found between Full Threshold techniques (SAP III and SAP V) and the 
Matrix in comparison to SAP V and SS. 
 
Table 4.6:  Test Duration Regression Analysis______________________________________________ 
                FT SAP 10-2 size V          SITA SAP 10-2 size III           Matrix 10-2 size 2˚ 
_____________________________________________________________________________________ 
 
FT SAP 10-2 size III r 2= 0.0550 (p=0.1048) r 2= 0.1301 (p=0.0109) r2 = 0.1273 (p=0.0118) 
 
FT SAP 10-2 size V            n/a  r2 = 0.1989 (p=0.0013) r 2= 0.0387 (p=0.1754) 
 
SITA SAP 10-2 size III  r2= 0.1989 (p=0.0013)              n/a  r2= 0.0176 (p=0.3640) 
_____________________________________________________________________________________ 
 




Previous studies have demonstrated uniform test-retest variability for M2 over its entire dynamic 
range in patients with early to moderate visual field loss67.  We examined patients with late stage 
glaucoma using perimetry techniques which measure the central 10˚ visual field using both 
Frequency Doubling Perimetry and Standard Automated Perimetry.   
 
Coefficients of variability and repeatability were calculated to give a global analysis for each 
technique across the full range of data. The Matrix gave the highest scores in each measurement 
thereby suggesting that it was the most variable and least repeatable technique.  Of the HFA 
techniques SAP V gave the most repeatable results due to its larger size and greater spatial 
summation97, but surprisingly SAP III was more repeatable than SS III as longer test duration is 
expected to result in patient fatigue.  However, these measures summate data from the entire 
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dynamic range.  The point-by-point analysis in Figure 4.3 describes in detail the repeatability at 
specific sensitivity estimates.   
 
In order to compare the decibel scales of both instruments, it should be noted that a 1dB change 
in threshold estimate is equal to 0.05 log units of contrast sensitivity for the FDP and 0.1 log units 
for SAP67.  Test-retest intervals for comparison between techniques are dependent upon the 
measurement scale, and therefore should be taken into account when comparing M2 results with 
that of SAP.  Principal curve analyses comparing the techniques show just that.  An 
approximately linear correlation is seen between SAP III and SS III.  Hence, graphs comparing 
SAP V with SAP III and SS III are fairly similar.  With sensitivity >25 dB, there is a strong 
correlation between the two techniques, in both comparisons, a slope of approximately 2.0, yet SS 
III and SAP III both calculate points as being more defective than SAP V at threshold estimates 
of <25 dB.  The difference in threshold estimate is due to the difference in stimulus size used for 
each technique.  The Goldmann stimulus size V is approximately 16 times larger than that of size 
III and therefore is capable of stimulating a larger receptive field in the retina allowing for the 
patient to see “more” of the points than when a Goldmann size III stimulus is used.  Despite the 
fact that the stimulus size for M2 and SAP V are almost the same size, large variability is seen 
between threshold estimates of these two techniques; in areas of SAP V sensitivities of >25 dB 
there is a strong linear correlation with a slope of approximately 3.0.  Figures 4.2 middle left and 
bottom right are in agreement with the study by Artes et al67 where threshold estimates between 
SAP (techniques with size III stimulus) and Matrix are being compared; in points with high 
sensitivity thresholds (>25 dB) a strong linear correlation is seen between the instruments; a slope 
of approximately 2.0.  This difference in sensitivity estimates is attributed to the difference in dB 
scale used by each instrument. 
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Point-by-point analysis (Figure 4.3) and Bland & Altman graphs (Figure 4.4) of threshold 
estimates showed variability among the techniques.  Comparing SAP III with SAP V showed that 
variability between the two techniques decrease at locations with sensitivity values greater than 
25 dB; SAP III shows more points outside normal limits with respect to threshold estimates less 
than 25 dB.  This was as expected as the Goldmann size V stimulus is 16 times larger than 
Goldmann size III; hence, greater spatial summation.  A similar trend is seen when SAP III and 
SS III are compared however, threshold estimates at the lower dynamic range are less variable 
than the first comparison.  Threshold estimates between these two techniques are shown to be 
very similar; this was expected as previous studies have shown that the SITA algorithm decreased 
test time without decreasing test reliability51.  SAP V vs SS III showed decreased variability at 
both ends of the dynamic range with SS III recording more test locations outside normal limits.  
Again, this is due to the difference in the size of the stimulus.  Test-retest analysis of SAP 
techniques plotted against threshold estimates of the M2 showed consistent variability throughout 
the dynamic range.  Compared to SAP III, the M2 estimates threshold points as less severe.  The 
same is true for most points on the graph comparing the M2 with SITA SAP III.  SAP V 
compared with the M2 showed that at threshold estimates of >20 dB M2 was estimated as 
approximately 30 dB. 
 
Comparing the defect score graphs of the total and pattern deviation probability maps indicate 
that the techniques available on SAP graded more test locations outside normal limits than that of 
M2.  This may be due to the difference in normal database, such as the inclusion criterion for the 
“normal” population106, available for each technique and the difference in target size and 
properties between the Goldmann size III and the Matrix 2 degrees.   
 
As expected, significant difference was seen in test duration between Full Threshold techniques 
when compared to SITA7, 29, 50.  No difference was seen between SAP III and SAP V.  Even with 
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the difference in stimulus size, no significant difference was noted between SAP III and SAP V; 
this was also seen with SITA and M2.  Despite the fact that SAP III and SAP V had no significant 
difference in test duration, in comparison to M2, SAP V showed no difference while SAP III 
showed a significant difference.  However, the results from this analysis are not reliable as the 
power values are <0.3 and <0.2, respectively.    
 
With respect to the other techniques, M2 showed constant variability when measuring the central 
10˚ visual field of patients with late stage glaucoma across the entire dynamic range but was 
greatest compared to SAP in the normal to near normal range of sensitivities.  This study goes to 
show that the current algorithm available on M2 is better suited to measure visual field sensitivity 
in the later stages of glaucoma than SAP despite the fact that it was designed for early detection 



















The within and between test repeatability of techniques available on the Humphrey Field 
Analyser and Matrix perimeter for the measurement of the central 10˚ visual field, were 
compared in patients with late stage glaucoma.  The following techniques were used:  Full 
Threshold SAP 10-2 size III, Full Threshold SAP 10-2 size V, SITA SAP 10-2 size III and Matrix 
10-2 size 2˚.  Each patient was examined on three separate occasions with four techniques.  The 
results of only the last two visits were used for analysis to eliminate learning effect bias.  Test-
retest variability in perimetry is dependent upon stimulus characteristics such as target size and 
color97, the stage of visual field defect being studied77 and the algorithm used to estimate the 
sensitivity52.  It is therefore important to determine the repeatability within a technique to decide 
whether or not it might be suitable to measure visual field loss and/or progression.  Previous 
studies have reported that the Matrix has uniform test-retest variability across its dynamic range 
in patients with early to moderate glaucomatous visual field loss in comparison to standard 
automated perimetry67, which tends to have worse test-retest characteristics with deepening defect.  
 
Overall, variability of SAP techniques follow the same trend:  it decreases as sensitivity increases.  
However, variability of this trend is seen between techniques.  The relative repeatability of 
techniques available on the HFA was as expected.  Standard AP III had the widest variability and 
SAP V had the narrowest.  This agrees with previous studies which show that SAP using a 
Goldmann size V stimulus is more suitable for monitoring visual field progression in late stage 
glaucoma than either technique using size III stimulus104.  Increased test duration is reported to 
increase variability of test results107, 108.  Hence, SAP III was found to be more variable than SS.  
Despite its short test duration, the Matrix showed greatest test-retest variability in the normal to 
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near-normal range of sensitivities. This may be due to the limited number of questions asked, 4 at 
each test location, and the limited number of end points available (15 as opposed to the 38 
available on SAP) during the Matrix ZEST threshold estimation algorithm.  Test duration showed 
no significant difference between visits, with the Full Threshold techniques taking the longest and 
M2 the shortest amount of time.  The techniques with a normal database also showed no 
significant difference in any of the global indices.  Coefficients of variability and repeatability 
were calculated to give a global analysis for each technique across the full range of data. The 
Matrix gave the highest scores in each measurement thereby suggesting that it was the most 
variable and least repeatable technique.  However, these measures summate data from the entire 
dynamic range.  The point-by-point analysis describes in detail the repeatability at specific 
sensitivity estimates. 
 
Point-by-point test-retest analysis showed the variability of threshold estimates within and among 
the techniques.  In the techniques available on SAP, variability increased with decreasing 
sensitivity.  Variability of the Matrix was constant throughout its dynamic range and was greatest 
in the normal to near-normal sensitivity values in comparison to SAP.  Full Threshold size V vs 
SITA SAP 10-2 size III showed decreased variability at both ends of the dynamic range with SS 
III recording more test locations as more severe.  Compared to all of the SAP techniques, the 
Matrix estimated sensitivity as more severe.  SAP 10-2 size V compared with the Matrix showed 
that estimated sensitivities of 20 dB and above on the Matrix were estimated at approximately 30 
dB with size V.  All SAP techniques show upper limits of their range of repeatability, particularly 
in the 10 to 20 dB range, to be no better than chance for measuring the same sensitivity at 
repeated visits.   
 
Total and pattern deviation defect scores showed variability within each technique; SAP 
classified more test locations outside normal limits than that of the Matrix with respect to the 
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pattern deviation probability plots.  This analysis has limited significance as total and pattern 
deviation probability calculations depend on the normal database which is unique to each 
technique, such as the inclusion criterion for the “normal” population106; differences in target size 
and stimulus type between the Goldmann size III and the Matrix size 2 degrees may also 
influence this outcome.  One of the limitations of the study was that there was no normal database 
available for the Full Threshold SAP 10-2 size V technique.  The lack of this data did not allow 
comparison of the total and pattern deviation probability plots of this technique with that of the 
others used in this study.   
 
In conclusion, this study showed that test-retest variability of the SAP techniques decreased with 
increasing sensitivity whereas; variability was constant throughout the dynamic range for M2 and 
smaller in the moderate to severe range.  However M2 was worst in the normal to near-normal 
sensitivity range.  This suggests that M2, compared to all SAP techniques, will be disadvantaged 
for the detection of early visual field loss, as reflected in the reduced number of abnormal points 
in the TD and PD plots, but may be better positioned to repeatably detect and follow moderate to 
severe loss in the central 10˚ of patients with late stage glaucoma.  
 
Previous studies have demonstrated a uniform test-retest variability of the Matrix over its entire 
dynamic range in patients with early to moderate visual field loss67; which is in agreement with 
this study.  Despite the fact that the Matrix was designed to detect early visual field loss, 
threshold estimates in the normal to near-normal sensitivity range had the greatest test-retest 
variability.  The study showed that the current algorithm for threshold estimation on the Matrix 
may not be suitable for the detection of early glaucoma, in spite of the technique being developed 
with this in mind.  However it is possible that the Matrix would provide the best means by which 
to measure visual field progression in moderate to late stage.  Altering the algorithm of the Matrix 
to increase the number of final threshold estimates, may help decrease the test-retest 
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characteristics in the near normal range, which in turn would help identify more abnormal points.  
This would require additional questions and therefore take more time, but could potentially make 
the Matrix the most obvious choice for a full scope technique for the detection and management 
of glaucoma.   
 
For automated perimetry to be able to define, with its greatest efficiency, the status of visual field 
defect(s) in glaucoma, it may be most appropriate to change the technique used at different stages 
of the disease process.  This study suggests the following:  SS III be used for the early detection 
of glaucomatous visual field damage;  SAP V should be considered for monitoring disease 
progression as it is the least variable technique in the moderate defect range.  The Matrix as 
presently configured, is best suited to monitor progression in the later stages of the disease.  It is 
theoretically possible that each technique could adopt refined threshold estimation techniques that 















6 Limitations of the Study  
 
Although the study was carried through as precisely as possible, there were several limitations to 
this study, most of which has to do with data analysis.  First of which was the fact that the normal 
database is unique to each technique.  This affects visual field indices and probability plot 
calculations, which were compared without accounting for this difference.  Standard AP size V, 
did not have a normal database and was excluded from visual field indices and probability plot 
calculations.   
 
Second was the difference in test location co-ordinates between the two instruments of which data 
points had to be recalculated for any comparison to be made.  
 
Test-time for each technique was different for each technique, which may have resulted in 
variability of the data that was due to test duration and not technique algorithm. 
And last but not least, all data that was analysed was subjective to each patient, although careful 
attention was given to ensure that each test was performed properly and only reliable tests were 
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